Photodynamic therapy with photosensitizer photolon for oral leukoplakia

The objective – to assess tolerability, safety and immediate results of treatment of patients with oral leukoplakia using photodynamic therapy (PDT) with a photosensitizer photolon. The study included 40 patients (7 men, 33 women) with morphologically verified leukoplakia of the oral mucosa. The ave...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. P. Istomin, T. P. Artemyeva, D. A. Tzerkovsky
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2016-07-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/88
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839574613404680192
author Yu. P. Istomin
T. P. Artemyeva
D. A. Tzerkovsky
author_facet Yu. P. Istomin
T. P. Artemyeva
D. A. Tzerkovsky
author_sort Yu. P. Istomin
collection DOAJ
description The objective – to assess tolerability, safety and immediate results of treatment of patients with oral leukoplakia using photodynamic therapy (PDT) with a photosensitizer photolon. The study included 40 patients (7 men, 33 women) with morphologically verified leukoplakia of the oral mucosa. The average age – 55±14 years. Number of treated foci – 109 (1 to 8). Photolon was administered intravenously at doses of 1.7-2.5 mg/kg. Photoirradiation («UPL PDT», Belarus, λ = 660±5 nm) was performed 2.5-3 h after administration: light exposure dose varied from 25 to 100 J/cm2, power density of 0.07 to 0.32 W/cm2, the duration of one field photoirradiation – from 2 to 13.5 min and according to its linear dimensions. The effectiveness of treatment was assessed 1-2 months after PDT by clinical data. Complete regression of foci recorded in 95% of cases (n=38), partial – in 5% (n=2).The follow-up period varied from 1 to 30 months. Full-epithelialization of the wound defect occurred within the period of 3-6 weeks after treatment. Photodynamic therapy may be recommended for patients with circumscribed or widespread oral leukoplakia as a simple, well-tolerated and effective option. Keywords: photodynamic therapy, photolon, oral leukoplakia.
format Article
id doaj-art-c81a3265ad8f44acb5fda0de81aa5a93
institution Matheson Library
issn 2413-9432
language Russian
publishDate 2016-07-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj-art-c81a3265ad8f44acb5fda0de81aa5a932025-08-04T13:14:23ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322016-07-0152132010.24931/2413-9432-2016-5-2-13-2085Photodynamic therapy with photosensitizer photolon for oral leukoplakiaYu. P. Istomin0T. P. Artemyeva1D. A. Tzerkovsky2N.N. Alexandrov National Cancer Centre of BelarusN.N. Alexandrov National Cancer Centre of BelarusN.N. Alexandrov National Cancer Centre of BelarusThe objective – to assess tolerability, safety and immediate results of treatment of patients with oral leukoplakia using photodynamic therapy (PDT) with a photosensitizer photolon. The study included 40 patients (7 men, 33 women) with morphologically verified leukoplakia of the oral mucosa. The average age – 55±14 years. Number of treated foci – 109 (1 to 8). Photolon was administered intravenously at doses of 1.7-2.5 mg/kg. Photoirradiation («UPL PDT», Belarus, λ = 660±5 nm) was performed 2.5-3 h after administration: light exposure dose varied from 25 to 100 J/cm2, power density of 0.07 to 0.32 W/cm2, the duration of one field photoirradiation – from 2 to 13.5 min and according to its linear dimensions. The effectiveness of treatment was assessed 1-2 months after PDT by clinical data. Complete regression of foci recorded in 95% of cases (n=38), partial – in 5% (n=2).The follow-up period varied from 1 to 30 months. Full-epithelialization of the wound defect occurred within the period of 3-6 weeks after treatment. Photodynamic therapy may be recommended for patients with circumscribed or widespread oral leukoplakia as a simple, well-tolerated and effective option. Keywords: photodynamic therapy, photolon, oral leukoplakia.https://www.pdt-journal.com/jour/article/view/88istomin yu.p.artemyeva t.p.tzerkovsky d.a. photodynamic therapy with photosensitizer photolon for oral leukoplakiabiomedical photonics2016t. 5no. 2pp. 13–20 (in russian)
spellingShingle Yu. P. Istomin
T. P. Artemyeva
D. A. Tzerkovsky
Photodynamic therapy with photosensitizer photolon for oral leukoplakia
Biomedical Photonics
istomin yu.p.
artemyeva t.p.
tzerkovsky d.a. photodynamic therapy with photosensitizer photolon for oral leukoplakia
biomedical photonics
2016
t. 5
no. 2
pp. 13–20 (in russian)
title Photodynamic therapy with photosensitizer photolon for oral leukoplakia
title_full Photodynamic therapy with photosensitizer photolon for oral leukoplakia
title_fullStr Photodynamic therapy with photosensitizer photolon for oral leukoplakia
title_full_unstemmed Photodynamic therapy with photosensitizer photolon for oral leukoplakia
title_short Photodynamic therapy with photosensitizer photolon for oral leukoplakia
title_sort photodynamic therapy with photosensitizer photolon for oral leukoplakia
topic istomin yu.p.
artemyeva t.p.
tzerkovsky d.a. photodynamic therapy with photosensitizer photolon for oral leukoplakia
biomedical photonics
2016
t. 5
no. 2
pp. 13–20 (in russian)
url https://www.pdt-journal.com/jour/article/view/88
work_keys_str_mv AT yupistomin photodynamictherapywithphotosensitizerphotolonfororalleukoplakia
AT tpartemyeva photodynamictherapywithphotosensitizerphotolonfororalleukoplakia
AT datzerkovsky photodynamictherapywithphotosensitizerphotolonfororalleukoplakia